Regal Partners Ltd lessened its position in shares of Anteris Technologies Global Corp. (NASDAQ:AVR - Free Report) by 30.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 896,164 shares of the company's stock after selling 397,697 shares during the quarter. Anteris Technologies Global comprises 0.3% of Regal Partners Ltd's portfolio, making the stock its 27th biggest holding. Regal Partners Ltd owned approximately 2.49% of Anteris Technologies Global worth $3,262,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in AVR. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Anteris Technologies Global during the fourth quarter valued at approximately $33,000. Deutsche Bank AG purchased a new stake in Anteris Technologies Global during the first quarter valued at approximately $59,000. Nuveen LLC purchased a new stake in Anteris Technologies Global during the first quarter valued at approximately $71,000. Persistent Asset Partners Ltd purchased a new stake in Anteris Technologies Global during the first quarter valued at approximately $85,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Anteris Technologies Global in the first quarter worth approximately $91,000.
Anteris Technologies Global Trading Up 3.1%
Shares of NASDAQ AVR traded up $0.12 during midday trading on Friday, hitting $4.04. The company's stock had a trading volume of 117,310 shares, compared to its average volume of 117,236. The business's 50 day moving average is $3.71 and its two-hundred day moving average is $4.68. Anteris Technologies Global Corp. has a 12-month low of $2.34 and a 12-month high of $8.79.
Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last issued its quarterly earnings results on Monday, August 11th. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.53) by ($0.05). The firm had revenue of $0.62 million during the quarter, compared to analysts' expectations of $0.58 million. On average, sell-side analysts expect that Anteris Technologies Global Corp. will post -2.66 earnings per share for the current year.
Anteris Technologies Global Company Profile
(
Free Report)
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Further Reading

Before you consider Anteris Technologies Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.
While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.